Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02212314
What this trial is testing

Response Inhibition Training for Children With Williams Syndrome

Who this might be right for
Williams Syndrome
University of Wisconsin, Milwaukee 25
Large-scale testing (Phase 3)Ended earlyNCT01583114
What this trial is testing

PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors

Who this might be right for
Dilated Cardiomyopathy
Institut National de la Santé Et de la Recherche Médicale, France 6
Not applicableStudy completedNCT05155865
What this trial is testing

Conduction System Pacing Versus Biventricular Pacing for Cardiac ResYNChronization

Who this might be right for
Dilated Cardiomyopathy with Conduction DefectLeft Bundle-Branch BlockHeart Failure+2 more
University Medical Centre Ljubljana 62
Not applicableStudy completedNCT01585831
What this trial is testing

Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome

Who this might be right for
Klinefelter SyndromeXXY Syndrome
University of Colorado, Denver 48
Large-scale testing (Phase 3)Study completedNCT03843541
What this trial is testing

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Who this might be right for
Respiratory Tract DiseasesAbnormal Mucus Secretions
Zambon SpA 333
Testing effectiveness (Phase 2)Study completedNCT01525875
What this trial is testing

Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Pseudoxanthoma Elasticum
Mark Lebwohl 44
Early research (Phase 1)Ended earlyNCT06597656
What this trial is testing

A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 3
Early research (Phase 1)WithdrawnNCT06483802
What this trial is testing

ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia

Who this might be right for
Friedreich AtaxiaCardiomyopathy
Astellas Gene Therapies
Early research (Phase 1)Study completedNCT06673654
What this trial is testing

A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Sun Pharmaceutical Industries, Inc. 476
Testing effectiveness (Phase 2)Study completedNCT03489629
What this trial is testing

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

Who this might be right for
Cystic Fibrosis
University of North Carolina, Chapel Hill 49
Not applicableStudy completedNCT01974830
What this trial is testing

AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry

Who this might be right for
Alpha-1 Anti-trypsin Deficiency
Coram Clinical Trials 120
Not applicableStudy completedNCT04458766
What this trial is testing

The Use of Mobile Health Technology and Behavioral Economics to Encourage Adherence in Adolescents

Who this might be right for
Familial HypercholesterolemiaAdherence, Medication
Boston Children's Hospital 11
Not applicableStudy completedNCT02830477
What this trial is testing

Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

Who this might be right for
Hemophilia A, Congenital
Bayer 313
Testing effectiveness (Phase 2)Study completedNCT02536170
What this trial is testing

Arginine Therapy for Sickle Cell Disease Pain

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode
Emory University 108
Testing effectiveness (Phase 2)Study completedNCT04284657
What this trial is testing

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
University of Southern California 1
Large-scale testing (Phase 3)Study completedNCT02987257
What this trial is testing

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolyses
Vanderbilt University Medical Center 2
Not applicableStudy completedNCT03664167
What this trial is testing

Weight Loss for Obese Individuals With Gout

Who this might be right for
Gout, Arthritis, Obesity
Henning Bliddal 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06421636
What this trial is testing

Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

Who this might be right for
Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals 19
Early research (Phase 1)WithdrawnNCT05158439
What this trial is testing

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome

Who this might be right for
Tourette Syndrome
The Foundation for Orthopaedics and Regenerative Medicine
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865
What this trial is testing

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 49
Next Page